Pneumonectomy
Disparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients With Operable Malignant Pleural Mesothelioma
JAMA Network Open 2023 March 1 [Link] Ahmed Alnajar, Samuel A Kareff, Syed S Razi, J Sunil Rao, Gilberto De Lima Lopes, Dao M Nguyen, Nestor Villamizar, Estelamari Rodriguez Abstract Importance: Outcomes of localized malignant pleural mesothelioma (MPM) remain poor despite multimodality therapy. It is unclear what role disparities have in the overall survival (OS)…
Read MoreSurgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial
The Lancet Oncology 2021 January 12 [Link] B C John Cho, Laura Donahoe, Penelope A Bradbury, Natasha Leighl, Shaf Keshavjee, Andrew Hope, Prodipto Pal, Michael Cabanero, Kasia Czarnecka, Karen McRae, Ming-Sound Tsao, Marc de Perrot Abstract Background: A novel approach for managing malignant pleural mesothelioma, surgery for mesothelioma after radiotherapy (SMART), consisting of a short…
Read MoreHyperthermic intraoperative intrapleural chemotherapy and surgical cytoreduction as part of multimodal treatment of malignant pleural mesothelioma – case report M. Szkorupa1, D. Klos1, J. Chudacek1, J. Hanuliak1, M. Stasek1, O. Fischer2, R. Lemstrova3
Rozhledy V Chirurgii Fall 2020 [Link] M Szkorupa, D Klos, J Chudacek, J Hanuliak, M Stasek, O Fischer, R Lemstrová Abstract Malignant pleural mesothelioma is one of the most aggressive malignancies with a very poor prognosis. Multimodal treatment consisting of three modalities – chemotherapy, radiotherapy and cytoreductive surgery is optimal. The use of new therapeutic…
Read MoreProton beam therapy for malignant pleural mesothelioma.
Translational Lung Cancer Research 2018 April 7 [Link] Badiyan SN, Molitoris JK, Zhu M, Glass E, Diwanji T, Simone CB Abstract Malignant pleural mesothelioma (MPM) is a rare disease with a poor prognosis. Surgical techniques have made incremental improvements over the last few decades while new systemic therapies, including immunotherapies, show promise as potentially effective…
Read MoreSurgical Options for Malignant Mesothelioma: A Single-Center Experience.
The Korean Journal of Thoracic and Cardiovascular Surgery 2018 June 5 [Link] Kang SR, Bok JS, Lee GD, Choi SH, Kim HR, Kim DK, Park SI, Kim YH Abstract BACKGROUND: We investigated the surgical outcomes of patients who underwent therapeutic surgery for malignant pleural mesothelioma (MPM) at a single center. METHODS: A retrospective review of…
Read MoreA Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma
Journal of Thoracic Oncology 2018 May 3 [Link] Burt BM, Richards WG, Lee HS, Bartel S, Dasilva MC, Gill RR, Jaklitsch MT, Johnson BE, Swanson SJ, Bueno R, Sugarbaker DJ Abstract INTRODUCTION: The primary objective of this single-institution Phase I clinical trial was to establish the maximum tolerated dose (MTD) of gemcitabine added to cisplatin…
Read MoreMultiple intracranial metastases from postoperative giant sarcomatoid malignant pleural mesothelioma: A case report and literature review
Molecular and Clinical Oncology 2018 January [Epub 2017 November 8] [Link] Tian D, Wen H, Brown HE, Wang X, Zhang L, Fu M Abstract Sarcomatoid malignant pleural mesothelioma (SMPM) is a rare tumor with poor response to treatment and a dismal prognosis. Distant metastases are not uncommon and usually appear at the late stages of…
Read MoreIs Pleurectomy/Decortication Superior to Extrapleural Pneumonectomy for Patients with Malignant Pleural Mesothelioma? A Single-Institutional Experience
Annals of Thoracic and Cardiovascular Surgery 2018 January [Epub ahead of print] [Link] Miyazaki T, Yamasaki N, Tsuchiya T, Matsumoto K, Kamohara R, Hatachi G, Nagayasu T Abstract PURPOSE: This study was performed to compare the outcome of pleurectomy/decortication (P/D) with that of extrapleural pneumonectomy (EPP) for patients with malignant pleural mesothelioma (MPM). METHODS: Patients…
Read MorePropensity matched comparison of extrapleural pneumonectomy and pleurectomy/decortication for mesothelioma patients
Interactive Cardiovascular and Thoracic Surgery 2017 May [Link] Kostron A, Friess M, Inci I, Hillinger S, Schneiter D, Gelpke H, Stahel R, Seifert B, Weder W, Opitz I Abstract OBJECTIVES: The objective of this retrospective study was to assess perioperative outcomes, overall survival and freedom from recurrence after induction chemotherapy followed by extrapleural pneumonectomy (EPP)…
Read MorePhysical function and health-related quality of life in patients undergoing surgical treatment for malignant pleural mesothelioma
Multinational Association of Supportive Care in Cancer 2017 March [Epub ahead of print] [Link] Tanaka T, Morishita S, Hashimoto M, Itani Y, Mabuchi S, Kodama N, Hasegawa S, Domen K Abstract Malignant pleural mesothelioma (MPM) is a rare cancer that affects the thin cell wall lining of internal organs and structures. Studies have shown that…
Read More